MannKind Stock (NASDAQ:MNKD), Quotes and News Summary

Q: What sector and industry does MannKind (MNKD) operate in?

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.

Open	$4.190
Close	$4.340
Volume / Avg.	2.507M / 2.868M
Day Range	4.150 - 4.393
52 Wk Range	3.170 - 5.750
Market Cap	$1.191B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	11.5%
Days to Cover	10.88

Recent News

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Avi Kapoor

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Avi Kapoor

What's Going On With MannKind Stock?

MannKind Corporation shares are trending on social media Monday. CNBC's Jim Cramer mentioned the stock on the "Mad Money Lightning Round" Friday. The stock has been "hanging out there forever, and it's finally starting to look like it's going to have an earnings breakout, but I am one of those people who's jaundiced about it. I got to wait to see if they come up with something," Cramer said.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MannKind (MNKD) stock?

You can purchase shares of MannKind (NASDAQ: MNKD) through any online brokerage.

View our list of the best stock brokerages.

Who are MannKind's (MNKD) competitors?

Other companies in MannKind’s space includes: Macrogenics (NASDAQ:MGNX), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the target price for MannKind (MNKD) stock?

The latest price target for MannKind (NASDAQ: MNKD) was reported by Cantor Fitzgerald on Friday, March 15, 2024. The analyst firm set a price target for 6.50 expecting MNKD to rise to within 12 months (a possible 47.73% upside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for MannKind (MNKD)?

The stock price for MannKind (NASDAQ: MNKD) is $4.4 last updated Today at May 1, 2024 at 5:33 PM EDT.

Does MannKind (MNKD) pay a dividend?

There are no upcoming dividends for MannKind.

When is MannKind (NASDAQ:MNKD) reporting earnings?

MannKind’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is MannKind (MNKD) going to split?

There is no upcoming split for MannKind.

What sector and industry does MannKind (MNKD) operate in?

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-